M&A Activity
The Aurora Ménage à Trois: Three Shifts in Seven Days
Curaleaf Holdings’ battle to acquire Aurora Cannabis has shifted in favour of the Canadian producer on multiple fronts over the last week.
organigram
38stories
14 Octlast updated
More in organigram
- M&A Activity
Has Rescheduling Accelerated the Cannabis M&A Wave?
Last week’s rescheduling announcement has placed a spotlight firmly on the medical cannabis arms of North America’s largest operators.
- Industry Trends
Organigram Acquires Sanity Group: When Big Tobacco Moves into Cannabis
By Dr Sebastian Marincolo, Director of Strategic Content & Editorial, Weed.de Canadian cannabis company Organigram Global has agreed to acquire Berlin’s Sanity Group for up to 227 million euros, financed in large part by a roughly 65 million Canadian dollar capital injection from its largest shareholder, British American Tobacco (BAT).
- Industry Trends
The Scramble for Europe
Last month, the German cannabis market saw its most significant consolidation deal to date, as Canadian heavyweight Organigram announced plans to acquire Sanity Group in a deal worth up to €250m.
- Uncategorized
Organigram ‘Fast-Tracks’ Entrance Into the US and THC-Beverages Market Through $24m Acquisition
Just days after announcing a comprehensive rebrand as it shifts its focus to international markets, Organigram Global has acquired Hamilton-based Collective Project Limited (CPL) in a deal worth up to C$24m.
- Uncategorized
Organigram Launches Rebrand as it Targets International Markets
Canadian cannabis giant Organigram has officially rebranded as it pivots its strategy towards international operations.
- Markets & Stocks
Organigram Gets Final Investment From Tobacco Giant, Kanabo Sees Double Digit Revenue Increase, & More From Curity Pharma
London Stock Exchange-listed (LSE) UK medical cannabis operator Kanabo has published its broad financial results for 2024, revealing growing revenue and falling losses.
- Markets & Stocks
BAT Announces 2nd £200m Fund With More Cannabis Investment Expected, Jazz Pharma Looks for New CEO, & Synbiotic Partners With Canna-Tech Firm
British American Tobacco [stock_market_widget type=”chart” template=”line” assets=”BATS.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Tobacco giant British American Tobacco (BAT) has announced the launch of a second investment fund as part of its corporate venture arm, Btomorrow Ventures (BTV).
- Markets & Stocks
Argent BioPharma Sees 74% Sales Decline, Cantourage Enjoys 62% Sales Increase, & Organigram Progresses With BAT Investment
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent BioPharma (formerly MGC Pharmaceuticals) has released its latest preliminary financial figures for the year to June 30, 2024, revealing a sharp drop in revenues but a reigning in of net losses compared to the previous year.
